Latest Selectin Stories

2011-11-18 03:44:19

The removal of rare tumor cells circulating in the blood might be possible with the use of biomolecules bound to dendrimers, highly branched synthetic polymers, which could efficiently sift and capture the diseased cells, according to new research at the University of Illinois at Chicago. Dendrimers have been used to encapsulate drug molecules and serve as a delivery vehicle, but in the new study they were employed to capture circulating tumor cells by biomimicry -- using nanotechnology to...

2009-12-10 07:00:00

CAMBRIDGE, Mass. Dec. 10 /PRNewswire/ -- The US Army, through the Telemedicine and Advanced Technology Research Center (TATRC), has awarded Energid Technologies a contract to develop a robotic approach to airway management. After trauma or injury, airway management typically involves clearing a patient's airway and inserting a tube to maintain oxygen flow in preparation for further treatment. This process, endotracheal intubation, is critical as the loss of proper air circulation is...

2008-09-08 12:00:08

GlycoMimetics has initiated a Phase I clinical trial for GMI-1070, its lead drug candidate for the treatment of vaso-occlusive crisis of sickle cell disease. The Phase I trial will evaluate the safety and pharmacokinetics of a single intravenous dose of GMI-1070 at a range of dose levels. The initial Phase I trial will be followed by additional multiple dose studies in healthy volunteers and, later, in sickle cell patients to further assess safety and to evaluate clinical effects....

2008-09-05 06:00:05

GlycoMimetics, Inc., a privately held company developing a new class of glycobiology-based therapies for a broad range of indications, today announced it has initiated a Phase 1 clinical trial for GMI-1070, its lead drug candidate for the treatment of vaso-occlusive crisis of sickle cell disease. "We are pleased to advance our lead drug candidate into clinical trials," said Rachel King, Chief Executive Officer of GlycoMimetics. "GMI-1070 possesses excellent drug-like properties and has...

2007-01-05 00:35:00

Associate Professor Michael King of the University of Rochester Biomedical Engineering Department has invented a device that filters the blood for cancer and stem cells.  When he captures cancer cells, he kills them.  When he captures stem cells, he harvests them for later use in tissue engineering, bone marrow transplants, and other applications that treat human disease and improve health.  With Nichola Charles, Jared Kanofsky, and Jane L. Liesveld of the University of...

Word of the Day
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.